[WS(O)29] Cell therapy, vaccine, and new therapeutic modality

12:50 〜 12:59

[WS29-01-O/P] Development of new adoptive T cell therapy that overcomes tumor heterogeneity with escape variant tumor clones.

^○Kiyoshi Yasui¹, Daisuke Ehara^1,2, Mitsuhiro Yoneda¹, Situo Deng¹, Sachiko Okamoto³, Yasunori Amaishi³, Daisuke Muraoka⁴, Naohisa Ogo⁵, Akira Asai⁵, Hiroyuki Murota², Hiroaki Ikeda¹ (1.Nagasaki Univ. Grad. Sch. of Biomed. Sci., Dept. of Oncology., 2.Nagasaki Univ. Grad. Sch. of Biomed. Sci., Dept. of Dermatology., 3.Tech. Development Ctr, Takara Bio Inc., 4.Aichi Cancer Ctr. Res. Inst., Div. of Translational Oncoimmunology., 5.Ctr. for Drug Discovery, Grad. Div. Pharm., Univ. of Shizuoka.)

キーワード：

T cell therapy、Tumor heterogeneity、CAR-T

閲覧にはパスワードが必要です

ログイン

または